New potential therapy that restores motor function being planned for clinical trial. Medical researchers at the University of Alberta have discovered a promising new therapy for Huntington disease that restores lost motor skills and may delay or stop the progression of the disease based on lab model tests

Cortex Pharmaceuticals, Inc. announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent that protects the use of Ampakine® molecules for the treatment or prevention of respiratory depression. The patent is licensed exclusively to Cortex from the University of Alberta, and is based on the pioneering research of Dr John Greer.

Hundreds of individuals in the engineering and geoscience communities honoured their peers at the 2011 Summit Awards^® Gala, Thursday, April 14th at the Calgary TELUS Convention Centre.

For more information about this year's finalists, please click the above link.

TEC Edmonton bridges the gap between science and commerce with a program it calls Executive in Residence.